Cargando…
TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration
The volume of biological, chemical and functional data deposited in the public domain is growing rapidly, thanks to next generation sequencing and highly-automated screening technologies. These datasets represent invaluable resources for drug discovery, particularly for less studied neglected diseas...
Autores principales: | Urán Landaburu, Lionel, Berenstein, Ariel J, Videla, Santiago, Maru, Parag, Shanmugam, Dhanasekaran, Chernomoretz, Ariel, Agüero, Fernán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145610/ https://www.ncbi.nlm.nih.gov/pubmed/31680154 http://dx.doi.org/10.1093/nar/gkz999 |
Ejemplares similares
-
TDR Targets: a chemogenomics resource for neglected diseases
por: Magariños, María P., et al.
Publicado: (2012) -
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
por: Berenstein, Ariel José, et al.
Publicado: (2016) -
ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics
por: Sun, Jiangming, et al.
Publicado: (2017) -
Author Correction: Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
por: Salas-Sarduy, Emir, et al.
Publicado: (2018) -
Potent and selective inhibitors for M32 metallocarboxypeptidases identified from high-throughput screening of anti-kinetoplastid chemical boxes
por: Salas-Sarduy, Emir, et al.
Publicado: (2019)